Search
for
Sort by
Research 571–600 of 1000+
- Hirsutism: from Brazil to a place near you
- Occupational alopecia or alopecia areata?
- Management of male pattern hair loss.
- Statement from the frontal fibrosing alopecia international expert alliance: SOFFIA 2024
- Patient-Reported Satisfaction with Hair Regrowth in a Study of Ritlecitinib in Alopecia Areata: Results from ALLEGRO-2b/3
- 43018 Safety Analysis of Baricitinib in Adult Patients with Severe Alopecia Areata From 2 Randomized Clinical Trials over a Median of 1.6 years and up to 3.6 Years of Exposure
- Safety and tolerability of low-dose oral minoxidil in adolescents: A retrospective review
- Dutasteride intralesional microinjections in combination with oral minoxidil vs. oral minoxidil monotherapy in men with androgenetic alopecia: a retrospective analysis of 105 patients
- Treatment of Alopecia in Children
- Microneedling improves minoxidil response in androgenetic alopecia patients by upregulating follicular sulfotransferase enzymes.
- Global expression profile and global genome methylation signatures in male patients with androgenetic alopecia
- An overview of female pattern hair loss
- An update on the pathophysiology of female pattern hair loss
- Quality of Life in Australian Women with Female Pattern Hair Loss
- Telogeneffluvium . Telogen effluvium
- Improvement in Patient‐Reported Emotional Symptoms and Activity Limitations due to Hair Loss in Patients With Alopecia Areata Treated With Ritlecitinib: Additional Analyses From ALLEGRO ‐2b/3
- Psychosocial and Occupational Burden on Caregivers of Adolescents With Alopecia Areata in Australia
- 723 - Efficacy of ritlecitinib in patients with alopecia areata by extent of hair loss at baseline: post hoc analysis of the phase 3 long-term ALLEGRO-LT study
- Integrated Safety Analysis of Ritlecitinib in Adolescent Patients with Alopecia Areata from the Randomized, Placebo-Controlled ALLEGRO Phase 2b/3 and Ongoing Open-Label Phase 3 ALLEGRO-LT Studies
- 42005 Sustained scalp, eyebrow, and eyelash hair regrowth with ritlecitinib through Week 48 in patients with alopecia areata: post hoc analysis of the ALLEGRO phase 2b/3 study
- Chronic Telogen Effluvium: Is it a Distinct Condition? A Systematic Review
- Trajectories For Scalp Hair Regrowth In Patients With Severe Alopecia Areata Treated With Baricitinib
- Eyebrows and Eyelashes Regrowth Across Different SALT Response Thresholds in Patients with Alopecia Areata: Outcomes from the BRAVE AA Clinical Program
- Reliability and validity of a measure to assess the health-related quality of life of women with alopecia areata
- 33774 Baricitinib results in eyebrow and eyelash growth in patients with alopecia areata who do not achieve 20% or less scalp hair loss
- Advances in hair growth
- Diffuse congenital hypotrichosis simplex with associated hair shaft fragility
- SULT1A1 (Minoxidil Sulfotransferase) enzyme booster significantly improves response to topical minoxidil for hair regrowth
- Novel “After Minoxidil” spray improves topical minoxidil compliance and hair style manageability
- Bitemporal alopecia areata